. . . "1" . "Hube\u0148\u00E1k, Jan" . . "Patients with bipolar disorder are vulnerable to developing obesity, hypertension, dyslipidimia, and type 2 diabetes mellitus. Additional risk factor is pharmacotherapy. Mood stabilizers including anticonvulsants and second generation antipsychotics have been linked to risk for adverse metabolic and cardiovascular changes. Disorders related to metabolic syndrome are key risk factors for developing coronary heart disease. Patients with bipolar disorder have higher standardized mortality ratios in comparison with general population. Cardiovascular disorders are the leading contributor to excessive death for somatic causes. Bipolar disorder and metabolic syndrome share features of hormonal, immunological, and autonomic nervous system dysregulation. Lifestyle may account, in part, for the premature mortality observed in bipolar disorder. It warrants screening, monitoring of metabolic and cardiovascular disorders, and early intervention should be a part of complex clinical care, especially in maintenance treatment."@en . . "Onemocn\u011Bn\u00ED bipol\u00E1rn\u00ED poruchou je spojeno se zv\u00FD\u0161en\u00FDm rizikem vzniku obezity a rozvoje hypertenze, dyslipid\u00E9mie a diabetes mellitus 2. typu. Dal\u0161\u00EDm rizikov\u00FDm faktorem vzniku metabolick\u00FDch poruch je farmakoterapie. S rizikem ne\u017E\u00E1douc\u00EDch metabolick\u00FDch a kardiovaskul\u00E1rn\u00EDch p\u0159\u00EDzank\u016F je spojena l\u00E9\u010Dba stabiliz\u00E1tory n\u00E1lady v\u010Detn\u011B antikonvulziv a l\u00E9\u010Dba antipsychotiky, p\u0159edev\u0161\u00EDm druh\u00E9 generace. Poruchy v r\u00E1mci metabolick\u00E9ho syndromu jsou pokl\u00E1d\u00E1ny za kl\u00ED\u010Dov\u00E9 rizikov\u00E9 faktory rozvoje srde\u010Dn\u00EDch koron\u00E1rn\u00EDch poruch. Nemocn\u00ED s bipol\u00E1rn\u00ED poruchou maj\u00ED vy\u0161\u0161\u00ED standardizovanou mortalitu v porovn\u00E1n\u00ED s obecnou populac\u00ED. Ke zv\u00FD\u0161en\u00E9 mortalit\u011B z t\u011Blesn\u00FDch p\u0159\u00ED\u010Din p\u0159isp\u00EDvaj\u00ED p\u0159edev\u0161\u00EDm kardiovaskul\u00E1rn\u00ED poruchy. Bipol\u00E1rn\u00ED porucha a metabolick\u00FD syndrom sd\u00EDlej\u00ED \u0159adu fyziologick\u00FDch mechanizm\u016F v\u010Detn\u011B hormon\u00E1ln\u00ED, imunologick\u00E9 a nervov\u011B vegetativn\u00ED dysregulace. Na p\u0159ed\u010Dasn\u00E9 mortalit\u011B pacient\u016F s bipol\u00E1rn\u00ED poruchou se \u010D\u00E1ste\u010Dn\u011B m\u016F\u017Ee pod\u00EDlet \u017Eivotn\u00ED styl nemocn\u00FDch. Vyhled\u00E1v\u00E1n\u00ED a monitorov\u00E1n\u00ED metabolick\u00FDch a kardiovaskul\u00E1rn\u00EDch poruch u nemocn\u00FDch s bipol\u00E1rn\u00ED poruchou a \u010Dasn\u00E9 intervence by m\u011Bly b\u00FDt sou\u010D\u00E1st\u00ED komplexn\u00ED klinick\u00E9 p\u00E9\u010De, zvl\u00E1\u0161t\u011B p\u0159i dlouhodob\u00E9 udr\u017Eovac\u00ED l\u00E9\u010Db\u011B."@cs . . "16" . "Psychiatrie" . "cardiovascular disorder; metabolic syndrome; bipolar disorders"@en . . "Metabolick\u00FD syndrom a bipol\u00E1rn\u00ED afektivn\u00ED porucha" . "Onemocn\u011Bn\u00ED bipol\u00E1rn\u00ED poruchou je spojeno se zv\u00FD\u0161en\u00FDm rizikem vzniku obezity a rozvoje hypertenze, dyslipid\u00E9mie a diabetes mellitus 2. typu. Dal\u0161\u00EDm rizikov\u00FDm faktorem vzniku metabolick\u00FDch poruch je farmakoterapie. S rizikem ne\u017E\u00E1douc\u00EDch metabolick\u00FDch a kardiovaskul\u00E1rn\u00EDch p\u0159\u00EDzank\u016F je spojena l\u00E9\u010Dba stabiliz\u00E1tory n\u00E1lady v\u010Detn\u011B antikonvulziv a l\u00E9\u010Dba antipsychotiky, p\u0159edev\u0161\u00EDm druh\u00E9 generace. Poruchy v r\u00E1mci metabolick\u00E9ho syndromu jsou pokl\u00E1d\u00E1ny za kl\u00ED\u010Dov\u00E9 rizikov\u00E9 faktory rozvoje srde\u010Dn\u00EDch koron\u00E1rn\u00EDch poruch. Nemocn\u00ED s bipol\u00E1rn\u00ED poruchou maj\u00ED vy\u0161\u0161\u00ED standardizovanou mortalitu v porovn\u00E1n\u00ED s obecnou populac\u00ED. Ke zv\u00FD\u0161en\u00E9 mortalit\u011B z t\u011Blesn\u00FDch p\u0159\u00ED\u010Din p\u0159isp\u00EDvaj\u00ED p\u0159edev\u0161\u00EDm kardiovaskul\u00E1rn\u00ED poruchy. Bipol\u00E1rn\u00ED porucha a metabolick\u00FD syndrom sd\u00EDlej\u00ED \u0159adu fyziologick\u00FDch mechanizm\u016F v\u010Detn\u011B hormon\u00E1ln\u00ED, imunologick\u00E9 a nervov\u011B vegetativn\u00ED dysregulace. Na p\u0159ed\u010Dasn\u00E9 mortalit\u011B pacient\u016F s bipol\u00E1rn\u00ED poruchou se \u010D\u00E1ste\u010Dn\u011B m\u016F\u017Ee pod\u00EDlet \u017Eivotn\u00ED styl nemocn\u00FDch. Vyhled\u00E1v\u00E1n\u00ED a monitorov\u00E1n\u00ED metabolick\u00FDch a kardiovaskul\u00E1rn\u00EDch poruch u nemocn\u00FDch s bipol\u00E1rn\u00ED poruchou a \u010Dasn\u00E9 intervence by m\u011Bly b\u00FDt sou\u010D\u00E1st\u00ED komplexn\u00ED klinick\u00E9 p\u00E9\u010De, zvl\u00E1\u0161t\u011B p\u0159i dlouhodob\u00E9 udr\u017Eovac\u00ED l\u00E9\u010Db\u011B." . . "T\u016Fma, Ivan" . . "Metabolick\u00FD syndrom a bipol\u00E1rn\u00ED afektivn\u00ED porucha"@cs . "8"^^ . "http://www.tigis.cz/images/stories/psychiatrie/2012/01/07_hubenak_psych_1-12.pdf" . "Metabolic Syndrome And Bipolar Affective Disorder"@en . . "1211-7579" . . "CZ - \u010Cesk\u00E1 republika" . "Metabolick\u00FD syndrom a bipol\u00E1rn\u00ED afektivn\u00ED porucha" . . "I, Z(MSM0021620816)" . "RIV/00179906:_____/12:10124353" . "2"^^ . "Metabolic Syndrome And Bipolar Affective Disorder"@en . . . . "2"^^ . . "[B49870765306]" . "Metabolick\u00FD syndrom a bipol\u00E1rn\u00ED afektivn\u00ED porucha"@cs . "149605" . "RIV/00179906:_____/12:10124353!RIV13-MZ0-00179906" . . .